RESTON, Va., Nov. 17 /PRNewswire-FirstCall/ -- PRA International , one of the world's leading clinical research organizations, today announced the election of a new director to its Board of Directors.
"Every day we pursue our mission -- to be the best clinical development organization in the world," said Pat Donnelly, president and chief executive officer. "This week, we took a step to enhance that mission by electing Judith Hemberger as a new director. Judith's in-depth, hands-on experience in the pharmaceutical and biotech industries will be a great asset to our board. Judith was also a past member of the Company's board from 1997 to 2001, and we welcome her valuable insights back to PRA."
Judith Hemberger, Ph.D., is an experienced global pharmaceutical and biotech industry executive. She is a co-founder of Pharmion Corporation and has served as its executive vice president and chief operating officer and a director since Pharmion's inception in 2000. Prior to this, Dr. Hemberger was a consultant to many healthcare companies. She also worked for 19 years at Marion Laboratories and successor companies Marion Merrell Dow and Hoechst Marion Roussel. Here, she was responsible for leading a number of strategic functions including professional education, global regulatory affairs, global medical affairs, and commercial development. In addition to PRA International and Pharmion, Dr. Hemberger also serves on the boards of Perrigo Company and Renovis, Inc.
Dr. Hemberger has been appointed to serve on the Company's compensation committee and the nominating and corporate governance committee.
About PRA International
PRA International is one of the world's leading clinical development organizations, with over 2,500 employees working from offices in North America, Europe, South America, Africa, Australia and Asia. PRA, an ISO 9001:2000 registered company, delivers services to its clients through a unique approach called Project Assurance(SM), which represents the company's commitment to reliable service delivery, program-level therapeutic expertise, global access to knowledge, and involved senior management.
To learn more about PRA International, please visit http://www.prainternational.com .
PRA InternationalCONTACT: Matt Bond, Senior Vice President and CFO of PRA International,+1-703-464-6300, or Analyst Contact, Kathy Waller of Financial RelationsBoard, +1-312-640-6696
Web site: http://www.prainternational.com/
